Compound Detail

CHEMBL4746128

Enter ChEMBL ID:

Free Research Context This compound will appear in recent viewed items on the research home for this browser.

Cl.NC1=NC(c2ccc(F)cc2)C2=C(N1)/C(=C/c1ccc(F)cc1)CN(S(=O)(=O)c1ccc(C(F)(F)F)cc1)C2

ChEMBL ↗ Properties Compare Identifier

Basic Information

ChEMBL ID	CHEMBL4746128
Phase	Preclinical
Structure Type	MOL
InChI Key	NXQGLWRLTZAAKV-PUBYZPQMSA-N
Parent Compound	CHEMBL4802571
Active Moiety	CHEMBL4802571

Targets

Activities

Assay Types

PK Parameters

Publications

Known Names

560.5

MW (Da)

4.98

ALogP

HBA

HBD

87.8

PSA (Å²)

0.44

QED

Ro5 Violations

Rot. Bonds

First in Class Prodrug

IC50 4 meas. best 5.48

Target	Type	Best pChEMBL	Mean pChEMBL	Best (nM)	# Data
HepG2 CHEMBL395	IC50	5.48	5.48	3300.0	1
SMMC-7721 CHEMBL613831	IC50	5.42	5.42	3800.0	1
L02 CHEMBL4296457	IC50	4.81	4.81	15400.0	1
Unchecked CHEMBL612545	IC50	4.61	4.61	24400.0	1

Top measurements by pChEMBL value

Target	Type	Rel.	Value	Units	pChEMBL	Assay	PubMed
HepG2	IC50	=	3300.0	nM	5.48	Cytotoxicity against human HepG2 cells assessed as reduction in cell viability i...	32371335
SMMC-7721	IC50	=	3800.0	nM	5.42	Cytotoxicity against human SMMC-7721 cells assessed as reduction in cell viabili...	32371335
L02	IC50	=	15400.0	nM	4.81	Cytotoxicity against human L02 cells assessed as reduction in cell viability inc...	32371335
Unchecked	IC50	=	24400.0	nM	4.61	Cytotoxicity against human HHL-5 cells assessed as reduction in cell viability i...	32371335

PubMed	DOI	Target Context	# Activities
32371335	10.1016/j.ejmech.2020.112366	RAW264.7	3
32371335	10.1016/j.ejmech.2020.112366	HepG2	1
32371335	10.1016/j.ejmech.2020.112366	SMMC-7721	1
32371335	10.1016/j.ejmech.2020.112366	Unchecked	1
32371335	10.1016/j.ejmech.2020.112366	L02	1

Data from ChEMBL 36 via Core Engine